Sponsor or institution

Clinical trials and research at Shandong First Medical University

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Shandong First Medical University that are recruiting, in China. By phase: Phase 2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
SHR-1139 Injection for Ulcerative Pyoderma Gangrenosum in Adults Phase 2 Jinan, Shandong Recruiting Jan 13, 2026
Evaluating CM336 for treating autoimmune bullous disease in adults Phase 2 Jinan Recruiting Mar 28, 2025
Yangxinshi tablets for improving exercise capacity in chronic coronary syndrome patients Phase 4 Chongqing, Chongqing Municipality and 31 other locations Recruiting Dec 14, 2023
Evaluating biomarkers for coronary heart disease prognosis — Jinan, Shandong Recruiting Jan 26, 2023

All recruiting trials (4)

Quick answers

How many clinical trials run by Shandong First Medical University are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.